100 related articles for article (PubMed ID: 30732961)
1. Five-year outcomes of sparing level IB in node-positive, human papillomavirus-associated oropharyngeal carcinoma: A safety and efficacy analysis.
Ross RB; Juloori A; Varra V; Ward MC; Campbell S; Woody NM; Murray E; Xia P; Greskovich JF; Koyfman SA; Joshi NP
Oral Oncol; 2019 Feb; 89():66-71. PubMed ID: 30732961
[TBL] [Abstract][Full Text] [Related]
2. Sparing bilateral neck level IB in oropharyngeal carcinoma and xerostomia outcomes.
Tam M; Riaz N; Kannarunimit D; Peña AP; Schupak KD; Gelblum DY; Wolden SL; Rao S; Lee NY
Am J Clin Oncol; 2015 Aug; 38(4):343-7. PubMed ID: 26208401
[TBL] [Abstract][Full Text] [Related]
3. Selectively sparing the submandibular gland when level Ib lymph nodes are included in the radiation target volume: An initial safety analysis of a novel planning objective.
Varra V; Ross RB; Juloori A; Campbell S; Tom MC; Joshi NP; Woody NM; Ward MC; Xia P; Koyfman SA; Greskovich JF
Oral Oncol; 2019 Feb; 89():79-83. PubMed ID: 30732963
[TBL] [Abstract][Full Text] [Related]
4. Submandibular gland-sparing radiation therapy for locally advanced oropharyngeal squamous cell carcinoma: patterns of failure and xerostomia outcomes.
Gensheimer MF; Liao JJ; Garden AS; Laramore GE; Parvathaneni U
Radiat Oncol; 2014 Nov; 9():255. PubMed ID: 25424729
[TBL] [Abstract][Full Text] [Related]
5. Level IB nodal involvement in oropharyngeal carcinoma: implications for submandibular gland-sparing intensity-modulated radiotherapy.
Yu Y; Daly ME; Farwell DG; Luu Q; Gandour-Edwards R; Donald PJ; Chen AM
Laryngoscope; 2015 Mar; 125(3):608-14. PubMed ID: 25215891
[TBL] [Abstract][Full Text] [Related]
6. Comparison of xerostomia incidence after three-dimensional conformal radiation therapy and contralateral superficial lobe parotid-sparing intensity-modulated radiotherapy for oropharyngeal and hypopharyngeal cancer.
Kawamoto T; Nihei K; Nakajima Y; Kito S; Sasai K; Karasawa K
Auris Nasus Larynx; 2018 Oct; 45(5):1073-1079. PubMed ID: 29397249
[TBL] [Abstract][Full Text] [Related]
7. Submandibular gland sparing when irradiating neck level IB in the treatment of oral squamous cell carcinoma.
Jackson WC; Hawkins PG; Arnould GS; Yao J; Mayo C; Mierzwa M
Med Dosim; 2019 Summer; 44(2):144-149. PubMed ID: 29778321
[TBL] [Abstract][Full Text] [Related]
8. The risk of level IB nodal involvement in oropharynx cancer: Guidance for submandibular gland sparing irradiation.
Lee NCJ; Kelly JR; Park HS; Yarbrough WG; Burtness BA; Husain ZA
Pract Radiat Oncol; 2017; 7(5):e317-e321. PubMed ID: 28356201
[TBL] [Abstract][Full Text] [Related]
9. Contribution of submandibular gland and swallowing structure sparing to post-radiation therapy PEG dependence in oropharynx cancer patients treated with split-neck IMRT technique.
Gensheimer MF; Nyflot M; Laramore GE; Liao JJ; Parvathaneni U
Radiat Oncol; 2016 Nov; 11(1):151. PubMed ID: 27846899
[TBL] [Abstract][Full Text] [Related]
10. Safety of contralateral submandibular gland sparing in locally advanced oropharyngeal cancers: A multicenter review.
Robin TP; Gan GN; Tam M; Westerly D; Riaz N; Karam SD; Lee N; Raben D
Head Neck; 2016 Apr; 38(4):506-11. PubMed ID: 25482748
[TBL] [Abstract][Full Text] [Related]
11. Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study.
Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Tu WY; Kirwan J; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1479-87. PubMed ID: 20934262
[TBL] [Abstract][Full Text] [Related]
12. Long-term quality of life after swallowing and salivary-sparing chemo-intensity modulated radiation therapy in survivors of human papillomavirus-related oropharyngeal cancer.
Vainshtein JM; Moon DH; Feng FY; Chepeha DB; Eisbruch A; Stenmark MH
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):925-33. PubMed ID: 25832685
[TBL] [Abstract][Full Text] [Related]
13. Outcomes and xerostomia after postoperative radiotherapy for oral and oropharyngeal carcinoma.
Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Tu WY; Kirwan J; Mendenhall WM
Head Neck; 2014 Oct; 36(10):1467-73. PubMed ID: 23996878
[TBL] [Abstract][Full Text] [Related]
14. Submandibular gland-sparing intensity modulated radiotherapy in the treatment of head and neck cancer: sites of locoregional relapse and survival.
Collan J; Kapanen M; Mäkitie A; Nyman H; Joensuu H; Tenhunen M; Saarilahti K
Acta Oncol; 2012 Jul; 51(6):735-42. PubMed ID: 22150115
[TBL] [Abstract][Full Text] [Related]
15. Risk factors and distribution features of level IB lymph nodes metastasis in nasopharyngeal carcinoma.
Zeng L; Zhang Q; Ao F; Jiang CL; Xiao Y; Xie HH; Tang YQ; Gong XC; Li JG
Auris Nasus Larynx; 2019 Jun; 46(3):457-464. PubMed ID: 30528104
[TBL] [Abstract][Full Text] [Related]
16. Feasibility and safety of neck level IB-sparing radiotherapy in nasopharyngeal cancer: a long-term single institution analysis.
Kim D; Keam B; Ahn SH; Choi CH; Wu HG
Radiat Oncol J; 2022 Dec; 40(4):260-269. PubMed ID: 36606303
[TBL] [Abstract][Full Text] [Related]
17. Predictors of Dysgeusia in Patients With Oropharyngeal Cancer Treated With Chemotherapy and Intensity Modulated Radiation Therapy.
Sapir E; Tao Y; Feng F; Samuels S; El Naqa I; Murdoch-Kinch CA; Feng M; Schipper M; Eisbruch A
Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):354-361. PubMed ID: 27473816
[TBL] [Abstract][Full Text] [Related]
18. Modern Image-Guided Intensity-Modulated Radiotherapy for Oropharynx Cancer and Severe Late Toxic Effects: Implications for Clinical Trial Design.
Ward MC; Ross RB; Koyfman SA; Lorenz R; Lamarre ED; Scharpf J; Burkey BB; Joshi NP; Woody NM; Prendes B; Houston N; Reddy CA; Greskovich JF; Adelstein DJ
JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1164-1170. PubMed ID: 27438230
[TBL] [Abstract][Full Text] [Related]
19. The effect of submandibular gland preservation during level 1B neck dissection on postoperative xerostomia.
Markey JD; Morrel WG; Wang SJ; Ryan WR
Auris Nasus Larynx; 2018 Feb; 45(1):123-127. PubMed ID: 28449980
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of intensity-modulated radiotherapy as primary treatment for oropharyngeal squamous cell carcinoma - a European singleinstitution analysis.
Bird T; De Felice F; Michaelidou A; Thavaraj S; Jeannon JP; Lyons A; Oakley R; Simo R; Lei M; Guerrero Urbano T
Clin Otolaryngol; 2017 Feb; 42(1):115-122. PubMed ID: 27185284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]